[1]
Kumar, S.; Patil, M.T.; Kataria, R.; Salunke, D.B. 11. Thiazole: A privileged scaffold in drug discovery.In: Chemical Drug Design; , , Gupta, G.K.; Kumar, V., Eds.;De Gruyter: Berlin, pp. , pp. 243-282.
[2]
Umezawa, H.; Maeda, K.; Takeuchi, T.; Okami, Y. New antibiotics, Bleomycin A and B. J. Antibiot., 1966, 19, 200-209.
[3]
Twentyman, P.R. Bleomycin-mode of action with particular reference to the cell cycle. Pharmacol. Ther., 1983, 23, 417-441.
[4]
(a) Stubbe, J.; Kozarich, J.W.; Wu, W.; Vanderwall, D.E. Bleomycins: A structural model for specificity, binding, and double strand cleavage. Acc. Chem. Res., 1996, 29, 322-330.
(b) Hecht, S.M. Bleomycin: New perspectives on the mechanism of action. J. Nat. Prod., 2000, 63, 158-168.
(c) Aso, M.; Kondo, M.; Suemune, H.; Hecht, S.M. Chemistry of the bleomycin-induced alkali-labile DNA lesion. J. Am. Chem. Soc., 1999, 121, 9023-9033.
[5]
Bagley, M.C.; Dale, J.W.; Merritt, E.A.; Xiong, X. Thiopeptide antibiotics. Chem. Rev., 2005, 105, 685-714.
[6]
(a) Kettenring, J.; Colombo, L.; Ferrari, P.; Tavecchia, P.; Nebuloni, M.; Vekey, K.; Gallo, G.G.; Selva, E. Antibiotic GE2270A: A novel inhibitor of bacterial protein synthesis. II. Structure elucidation. J. Antibiot., 1991, 44, 702-715.
(b) Suzumura, K.I.; Yokoi, T.; Funatsu, M.; Nagai, K.; Tanaka, K.; Zhang, H.; Suzuki, K. YM-266183 and YM-266184, novel thiopeptide antibiotics produced by Bacillus cereus isolated from a marine sponge II. Structure elucidation. J. Antibiot., 2003, 56, 129-134.
[7]
Ojika, M.; Suzuki, Y.; Tsukamoto, A.; Sakagami, Y.; Fudou, R.; Yoshimura, T.; Yamanaka, S. Cystothiazoles A and B, new bithiazole-type antibiotics from the myxobacterium Cystobacterfuscus. J. Antibiot., 1998, 51, 275-281.
[8]
Suzuki, Y.; Ojika, M.; Sakagami, Y.; Fudou, R.; Yamanaka, S. Cystothiazoles C-F, new bithiazole-type antibiotics from the Myxobacterium cystobacterfuscus. Tetrahedron, 1998, 54, 11399-11404.
[9]
Orjala, J.; Gerwick, W.H. Barbamide, a chlorinated metabolite with molluscicidal activity from the Caribbean cyanobacterium Lyngbya majuscule. J. Nat. Prod., 1996, 59(4), 427-430.
[10]
Clark, W.D.; Crews, P. A novel chlorinated ketide amino acid, herbamide A, from the marine sponge Dysideaherbacea. Tetrahedron Lett., 1995, 36, 1185-1188.
[11]
Tan, L.T.; Sitachitta, N.; Gerwick, W.H. The Guineamides, novel cyclic depsipeptides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscule. J. Nat. Prod., 2003, 66, 764-771.
[12]
Williams, P.G.; Yoshida, W.Y.; Moore, R.E.; Paul, V.J. Isolation and structure determination of obyanamide, a novel cytotoxic cyclic depsipeptide from the marine cyanobacterium lyngbyaconfervoides. J. Nat. Prod., 2002, 65, 29-31.
[13]
Luesch, H.; Williams, P.G.; Yoshida, W.Y.; Moore, R.E.; Paul, V.J. U longamides A−F, New β-amino acid-containing cyclodepsipeptides from Palauan collections of the marine cyanobacteriumLyngbya sp. J. Nat. Prod., 2002, 65, 996-1000.
[14]
Williams, P.G.; Luesch, H.; Yoshida, W.Y.; Moore, R.E.; Paul, V.J. Continuing studies on the Cyanobacterium Lyngbya sp.: Isolation and structure determination of 15-norlyngbyapeptin A and lyngbyabellin D. J. Nat. Prod., 2003, 66, 595-598.
[15]
Marquez, B.L.; Watts, K.S.; Yokochi, A.; Roberts, M.A.; Pinard, P.V.; Jimenez, J.I.; Hamel, E.; Scheuer, P.J.; Gerwick, W.H. Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly. J. Nat. Prod., 2002, 65, 866-871.
[16]
Suntornchashwej, S.; Chaichit, N.; Isobe, M.; Suwanborirux, K. Hectochlorin and morpholinederivatives from the Thai sea hare. Bursatellaleachii. J. Nat. Prod, 2005, 68, 951-955.
[17]
Sudek, S.; Haygood, M.G.; Youssef, D.T.A.; Schmidt, E.W. Structure of trichamide, a cyclic peptide from the bloom-forming cyanobacterium Trichodesmium erythraeum, predicted from the genome sequence. Appl. Environ. Microbiol., 2006, 72, 4382-4387.
[18]
Schmidt, E.W.; Nelson, J.T.; Rasko, D.A.; Sudek, S.; Eisen, J.A.; Haygood, M.G.; Ravel, J. Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella. Proc. Natl. Acad. Sci. USA, 2005, 102, 7315-7320.
[19]
Aaron, M.S.; Richard, A.L.; David, C.R. Bacillamides from a hypersaline microbial mat bacterium. J. Nat. Prod., 2007, 70, 1793-1795.
[20]
Yu, L.; Li, Z.; Peng, C.; Li, Z.; Guo, Y. Neobacillamide A, a novel thiazole-containing alkaloid from the marine bacterium Bacillus vallismortis C89, associated with South China Sea Sponge Dysideaavar. Helv. Chim. Acta, 2009, 92, 607-612.
[21]
Matsuo, Y.; Kanoh, K.; Imagawa, H.; Adachi, K.; Nishizawa, M.; Shizuri, Y. Urukthapelstatin A, a novel cytotoxic substance from marine-derived Mechercharimyces asporophorigenens YM11-542. J. Antibiot., 2007, 60, 256-260.
[22]
Williams, P.G.; Yoshida, W.Y.; Moore, R.E.; Paul, V.J. Micromide and guamamide: Cytotoxic alkaloids from a species of the marine cyanobacterium Symploca. J. Nat. Prod., 2004, 67, 49-53.
[23]
Linington, R.G.; González, J.; Ureña, L.; Romero, L.I.; Ortega-Barría, E.; Gerwick, W.H. Venturamides A and B: Antimalarial constituents of the panamanian marine Cyanobacterium oscillatoria sp. J. Nat. Prod., 2007, 70, 397-401.
[24]
Taori, K.; Paul, V.J.; Luesch, H. Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp. J. Am. Chem. Soc., 2008, 130, 1806-1807.
[25]
Pereira, A.; Cao, Z.; Murray, T.F.; Gerwick, W.H. Hoiamide A, a sodium channel activator of unusual architecture from a consortium of two Papua New Guinea cyanobacteria. Chem. Biol., 2009, 16, 893-906.
[26]
Pereira, A.; Cao, Z.; Murray, T.F.; Gerwick, W.H. Hoiamide A, a sodium channel activator of unusual architecture from a consortium of two Papua New Guinea cyanobacteria. Chem. Biol., 2009, 16, 1208.
[27]
Portmann, C.; Blom, J.F.; Gademann, K.; Jüttner, F. Aerucyclamides A and B: Isolation and synthesis of toxic ribosomal heterocyclic peptides from the cyanobacterium Microcystis aeruginosa PCC 7806. J. Nat. Prod., 2008, 71, 1193-1196.
[28]
Portmann, C.; Blom, J.F.; Kaiser, M.; Brun, R.; Jüttner, F.; Gademann, K. Isolation of Aerucyclamides C and D and structure revision of Microcyclamide 7806A: Heterocyclic ribosomal peptides from Microcystis aeruginosa PCC 7806 and their antiparasite evaluation. J. Nat. Prod., 2008, 71, 1891-1896.
[29]
Pettit, G.R.; Kamano, Y.; Herald, C.L.; Tuinman, A.A.; Boettner, F.E.; Kizu, H.; Schmidt, J.M.; Baczynkyji, L.; Tomer, K.B.; Bontems, R.J. The isolation and structure of a remarkable marine animal antineoplastic constituent: Dolastatin 10. J. Am. Chem. Soc., 1987, 109, 6883-6885.
[30]
Bai, R.; Pettit, G.R.; Hamel, E. Binding of Dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites. J. Biol. Chem., 1990, 265, 17141-17149.
[31]
Hamel, E. Interactions of antimitotic peptides and depsipeptides with tubulin. Biopolymers, 2002, 66, 142-160.
[32]
Pettit, G.R. The dolastatins. Fortschr. Chem. Org. Naturst., 1997, 70, 1-79.
[33]
Vaishampayan, H.; Glode, M.; Du, W.; Kraft, A.; Hudes, G.; Wright, J.; Hussain, M. Phase II study of Dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma. Clin. Cancer Res., 2000, 6, 4205-4208.
[34]
Margolin, K.; Longmate, J.; Synold, T.W.; Gandara, D.R.; Weber, J.; Gonzalez, R.; Johansen, M.J.; Newman, R.; Doroshow, J.H. Dolastatin-10 in metastatic melanoma: A phase II and pharmokinetic trial of the California Cancer Consortium. Invest. New Drugs, 2001, 19, 335-340.
[35]
Harrigan, G.G.; Luesch, H.; Yoshida, W.Y.; Moore, R.E.; Nagle, D.E.; Paul, V.J.; Mooberry, S.L.; Corbett, T.H.; Valeriote, F.A. Symplostatin 1: A Dolastatin 10 analogue from the marine cyanobacterium Symplocahydnoides. J. Nat. Prod., 1998, 61, 1075-1077.
[36]
Kazlauskas, R.; Lidgard, R.O.; Wells, R.J.; Vetter, W. A novel hexachloro-metabolite from the sponge Dysideaherbacea. Tetrahedron Lett., 1977, 18, 3183-3186.
[37]
Beaumont, S.; Ilardi, E.A.; Monroe, L.R.; Zakarian, A. Valence tautomerism in titanium enolates: Catalytic radical haloalkylation and application in the total synthesis of neodysidenin. J. Am. Chem. Soc., 2010, 132, 1482-1483.
[38]
Biskupiak, J.E.; Ireland, C.M. Revised absolute configuration of dysidenin and isodysidenin. Tetrahedron Lett., 1984, 25, 2935-2936.
[39]
Sande, J.V.; Deneubourg, F.; Beauwens, R.; Braekman, J.C.; Daloze, D.; Dumont, J.E. Inhibition of iodide transport in thyroid cells by dysidenin, a marine toxin, and some of its analogs. Mol. Pharmacol., 1990, 37, 583-589.
[40]
Flatt, P.; Gautschi, J.; Thacker, R.; Musafija-Girt, M.; Crews, P.; Gerwick, W. Identification of the cellular site of polychlorinated peptide biosynthesis in the marine sponge Dysidea (Lamellodysidea) herbacea and symbiotic cyanobacterium Oscillatoriaspongeliae by CARD-FISH analysis. Mar. Biol. (Berl), 2005, 147, 761-774.
[41]
Carroll, A.R.; Coll, J.C.; Bourne, D.J.; MacLeod, J.K.; Ireland, C.M.; Bowden, B.F. Patellins 1-6 and trunkamide A: Novel cyclic hexa-, hepta- and octa-peptides from colonial ascidians, Lissoclinum sp. Aust. J. Chem., 1996, 49, 659-667.
[42]
Rashid, M.A.; Gustafson, K.R.; Il, J.H.C.; Boyd, M.R. Patellamide F, a new cytotoxic cyclic peptide from the colonial ascidian lissoclinum patella. J. Nat. Prod., 1995, 58, 594-597.
[43]
Hamamoto, Y.; Endo, M.; Nakagawa, M.; Nakanishi, T.; Mizukawa, K. A new cyclic peptide, ascidiacyclamide, isolated from ascidian. J. Chem. Soc. Chem. Commun., 1983, 323-324.
[44]
McDonald, L.A.; Ireland, C.M.; Patellamide, E. A new cyclic peptide from the ascidian Lissoclinumpatella. J. Nat. Prod., 1992, 55, 376-379.
[45]
Ireland, C.M.; Durso, A.R., Jr; Newman, R.A.; Hacker, M.P. Antineoplastic cyclic peptides from the marine tunicate Lissoclinum patella. J. Org. Chem., 1982, 47, 1807-1811.
[46]
(a) Hamada, Y.; Shibata, M.; Shiori, T. New methods and reagents in organic synthesis. 58: A synthesis of patellamide A, a cytotoxic cyclic peptide from a tunicate. Revision of its proposed structure. Tetrahedron Lett., 1985, 26, 6501-6504.
(b) Reynaga, P.G.; Nieuwenhze, M.S.V. A new total synthesis of Patellamide A. Org. Lett., 2008, 10, 4621-4623.
[47]
Schmidt, E.W.; Nelson, J.T.; Rasko, D.A.; Sudek, S.; Eisen, J.A.; Haygood, M.G. Ravel, Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella. J. Proc. Natl. Acad. Sci. USA, 2005, 102, 7315-7320.
[48]
(a) Gouiffès, D.; Moreau, S.; Helbecque, N.; Bernier, J.L.; Henichart, J.P.; Barbin, Y.; Laurent, D.; Verbist, J.F. Proton nuclear magnetic study of bistramide A, a new cytotoxic drug isolated from Lissoclinum Bistratum sluiter. Tetrahedron, 1988, 44, 451-459.
(b) Gouiffès, D.; Jugé, M.; Grimaud, N.; Welin, L.; Barbin, Y.; Laurent, D.; Roussakis, C.; Hénichart, J.P.; Verbist, J.F. Bistramide A, a new toxin from the urochordata Lissoclinum bistratum sluiter: isolation and preliminary characterization. Toxicon, 1988, 26, 1129-1136.
[49]
(a) Romero, F.; Malet, L.; Cañedo, M.L.; Cuevas, C.; Reyes, F. WO Patent 000880 A2, 2005.
(b) Kanoh, K.; Matsuo, Y.; Adachi, K.; Imagawa, H.; Nishizawa, M.; Shizuri, Y. Mechercharmycins A and B, cytotoxic substances from marine-derived Thermoactinomyces sp. YM3-251. J. Antibiot., 2005, 58, 289-292.
[50]
Harrigan, G.G.; Goetz, G.H.; Luesch, H.; Yang, S.; Likos, J. Dysideaprolines A-F and barbaleucamides A-B, novel polychlorinated compounds from a Dysidea species. J. Nat. Prod., 2001, 64, 1133-1138.
[51]
Stapleton, B.L.; Cameron, G.M.; Garson, M.J. New chlorinated peptide from the tropical marine sponge Dysidea sp. Tetrahedron, 2001, 57, 4603-4607.
[52]
Arda, A.; Rodriguez, J.; Nieto, R.M.; Bassarello, C.; Gomez-Paloma, L.; Bifulco, G.; Jimenez, C. NMR J-based analysis of nitrogen-containing moieties and application to dysithiazolamide, a new polychlorinated dipeptide from Dysidea sp. Tetrahedron, 2005, 61, 10093-10098.
[53]
(a) Donia, M.S.; Wang, B.; Dunbar, D.C.; Desai, P.V.; Patny, A.; Avery, M.; Hamann, M.T. Mollamides B and C, cyclic hexapeptides from the indonesian tunicate Didemnummolle. J. Nat. Prod., 2008, 71, 941-945.
(b) Fritch, P.C.; Wipf, P. Total synthesis and assignment of configuration of Lissoclinamide 7. J. Am. Chem. Soc., 1996, 118, 12358-12367.
[54]
Kehraus, S.; Konig, G.M.; Wright, A.D.; Woerheide, G.; Leucamide, A. A new cytotoxic heptapeptide from the Australian sponge Leucettamicroraphis. J. Org. Chem., 2002, 67, 4989-4992.
[55]
Dalisay, D.S.; Rogers, E.W.; Edison, A.S.; Molinski, T.F. Structure elucidation at the nanomole scale. 1. Trisoxazole macrolides and thiazole-containing cyclic peptides from the nudibranch Hexabranchussanguineus. J. Nat. Prod., 2009, 72, 732-738.
